Expression of CD44 isoforms in human renal cell carcinomas

Virchows Archiv

Volumn 428, Issue 4-5, 1996, Pages 267-273

  Heider, Karl Heinz ^a,c   Ratschek, Manfred ^b   Zatloukal, Kurt ^b   Adolf, Günther R ^a  

^a BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c Bender+Co GesmbH ^*  (Austria)

Author keywords

CD44 isoforms; Chromophilic carcinomas; Immunohistochemistry; Normal kidney; Renal clear cell carcinomas

Indexed keywords

HERMES ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; PRIORITY JOURNAL; REACTION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029790863     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00196700     Document Type: Article

References (23)

1. Adolf G, Bodo G, Swetly P (1982) Production of monoclonal antibodies to human IFN-α and their use for analysis of the antigenic composition of various natural interferons. J Cell Physiol Suppl 2:61-68
2. Allen RW, Trach KA, Hoch JA (1987) Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 262:649-653
3. Brooks L, Niedohitek G, Agathanggelou A, Farrell P (1995) The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1. Am J Pathol 146:1102-1112
4. Dall P, Heider K-H, Hekele A, Minckwitz G von, Kaufmann M, Ponta H, Herrlich P (1994) Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 54:3337-3341
5. Fox SB, Fawcett J, Jackson DG (1994) Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54:4539-4546
6. Friedrichs K, Franke F, Lisboa B-W, Kügler G, Gille I, Terpe H-J, Hölzel F, Maass H, Günthert U (1995) CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55:5424-5433
7. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haußmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24
8. Haynes BF, Liao H-X, Patton KL (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple isoforms. Cancer Cells 3:347-350
9. Heider K-H, Dämmrich J, Skroch-Angel P, Müller-Hermelink H-K, Vollmers HP, Herrlich P, Ponta H (1993) Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53:4197-4203
10. Heider K-H, Hofmann M, Horst E, Berg F van den, Ponta H, Herrlich P, Pals ST (1993) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120:227-233
11. Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U (1991) CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292-5297
12. Kaufmann M, Heider K-H, Sinn H-P, Minckwith G von, Ponta H, Herrlich P (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345:615-619
13. Koopman G, Heider K-H, Horst E, Adolf GR, Berg F van den, Ponta H, Herrlich P, Pals ST (1993) Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897-904
14. Mayer B, Jauch KW, Günthert U, Figdor CG, Schildberg F, Funke I, Johnson JP (1993) De-novo expression of CD44 and survival in gastric cancer. Lancet 342:1019-1022
15. Mulder JWR, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offerhaus GJ, Pals ST (1994) Expression of exon v6 containing CD44 proteins in human colorectal cancer is associated with unfavorable prognosis in long term follow up. Lancet 344:1470-1472
16. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 82:12160-12164
17. Seiter S, Arch R, Reber S, Komitowsky D, Hofman M, Ponta H, Herrlich P, Matzku S, Zöller M (1993) Prevention of tumor metastatis formation by anti-variant CD44. J Exp Med 177:443-455
18. Stamenkovic I, Amiot M, Pesando JM, Seed B (1989) A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057-1062
19. Stauder R, Eisterer W, Thaler J, Günthert U (1995) CD44 variant isoforms in non-Hodgkin's lymphoma: a new independant prognostic factor. Blood 85:2885-2899
20. Terpe HJ, Tajrobehkar K, Günthert U, Altmannsberger M (1993) Expression of cell adhesion molecules alpha-2, alpha-5 and alpha-6 integrin, E-cadherin, N-CAM and CD44 in renal cell carcinomas. Virchows Arch [A] 422:219-224
21. Thoenes W, Störkel S, Rumpelt HJ (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). Pathol Res Pract 181:125-143
22. Tölg C, Hofmann M, Herrlich P, Ponta H (1993) Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:1225-1229
23. Wielenga VJ, Heider K-H, Offerhaus GJA, Adolf GR, Berg F van den, Ponta H, Herrlich P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754-4756